AGFG1 and Parkinson disease: The goal in this study, as samples from PD cohorts were not examined, was to assess the utility of assessing pRab10 and pRab12 rates (i.e., phosphorylated Rab as a proportion of total Rab expression) as a marker of target engagement, and as a proof of concept study, this was indeed demonstrated.